Recurrent Group B Streptococcus Neonatal Invasive Infections, France, 2007–2021 - Top-Institutions - MDSpire

Recurrent Group B Streptococcus Neonatal Invasive Infections, France, 2007–2021

  • By

  • Ghalia Sbaa

  • Nicolas Delettre

  • Cécile Guyonnet

  • Sébastien Le Huu Nghia

  • Caroline Joubrel-Guyot

  • Céline Plainvert

  • Claire Poyart

  • Asmaa Tazi

  • June 6, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Neonatology

  • #2

    Institut Pasteur
    Institut Pasteur

    Paris, France

    Key Differentiators

    • Microbiology
    • Infectious Diseases
    • Neonatology

  • #3

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Neonatology
    • Pediatric Infectious Diseases

  • #4

    University of Oxford, Nuffield Department of Medicine
    University of Oxford, Nuffield Department of Medicine

    Oxford, UK

    Key Differentiators

    • Infectious Diseases
    • Microbiology
    • Neonatology

  • #5

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Neonatology
    • Infectious Diseases
    • Genomics

Original Source(s)

Recurrent Group B Streptococcus Neonatal Invasive Infections, France, 2007–2021

  • by Ghalia Sbaa, Nicolas Delettre, Cécile Guyonnet, Sébastien Le Huu Nghia, Caroline Joubrel-Guyot, Céline Plainvert, Claire Poyart, Asmaa Tazi

  • June 6, 2024

Related Content

Characteristics and outcomes of type 2 myocardial infarction in sepsis survivors

Off by a beat: the effects of temporal misalignment in reinforcement learning for sepsis treatment

FDA Clears AI Sepsis Warning System

An FDA-cleared AI tool developed at Johns Hopkins detects sepsis up to 48 hours earlier than clinicians — and has cut related deaths by 18%.